BDBM281759 4-(2-cyano-1,2,3,4- tetrahydroisoquinolin- 5-yl)-3-fluoro-7-(2- hydroxyethyl)-9H- carbazole-1- carboxamide::US10023534, Example 27

SMILES NC(=O)c1cc(F)c(-c2cccc3CN(CCc23)C#N)c2c3ccc(CCO)cc3[nH]c12

InChI Key InChIKey=NOTIICHTQDOPAA-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 281759   

TargetTyrosine-protein kinase BTK(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM281759(4-(2-cyano-1,2,3,4- tetrahydroisoquinolin- 5-yl)-3...)
Affinity DataIC50: 4.80nMpH: 7.4 T: 2°CAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
Go to US Patent